Cell Therapy Manufacturing Automation Market Report Infographic Image

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Cell Therapy Manufacturing Automation Market Report 2026

Name: Cell Therapy Manufacturing Automation Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Component (Hardware, Software, Services), By Cell Type (T-Cells, Stem Cells, Natural Killer (NK) Cells, Other Cell Types), By Process (Upstream Processing, Downstream Processing, Fill-Finish, Quality Control, Other Processes), By End-User (Pharmaceutical And Biotechnology Companies, Research Institutes, Contract Manufacturing Organizations (CMOs), Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Cell Therapy Manufacturing Automation Market Overview

• Cell Therapy Manufacturing Automation market size has reached to $1.81 billion in 2025

• Expected to grow to $3.58 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%

• Growth Driver: Growing Demand For Gene Therapies Fueling The Growth Of The Market Due To The Need For Scalable, Standardized, And High-Quality Production Processes

• Market Trend: Automation Software Integration Drives Workflow Standardization

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cell Therapy Manufacturing Automation Market?

Cell therapy manufacturing automation refers to the use of automated, robot- or software-driven systems for cell isolation, expansion, processing, and quality control to improve scalability, consistency, and sterility in cell therapy production. This market includes automated closed-system bioreactors, robotic cell-handling platforms, automated cryopreservation units, integrated quality-control and monitoring tools, and software solutions for workflow control, electronic batch records, and GMP compliance.

The main components of cell therapy manufacturing automation solutions are hardware, software, and services. Hardware comprises automated processing equipment, bioreactors, and integrated systems that support scalable, consistent, and compliant cell therapy production workflows. These solutions are used across cell types including T-cells, stem cells, natural killer cells, and others, applied in upstream processing, downstream processing, fill-finish, quality control, and others, among end users such as pharmaceutical and biotechnology companies, research institutes, contract manufacturing organizations, and others.

Cell Therapy Manufacturing Automation market report bar graph

What Is The Cell Therapy Manufacturing Automation Market Size and Share 2026?

The cell therapy manufacturing market size has grown rapidly in recent years. It will grow from $1.81 billion in 2025 to $2.08 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to increasing cell-processing demand, growing manufacturing scalability needs, rising adoption of automated bioreactors, expansion of GMP-compliant workflows, and increasing focus on production consistency.

What Is The Cell Therapy Manufacturing Automation Market Growth Forecast?

The cell therapy manufacturing market size is expected to see rapid growth in the next few years. It will grow to $3.58 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to increasing personalized-therapy volumes, growing investment in automation platforms, rising need for contamination-free workflows, expansion of large-scale commercial manufacturing, and increasing regulatory-driven quality requirements. Major trends in the forecast period include technology advancements in closed systems, automation-driven process innovations, integrated workflow developments, real-time analytics research, and advanced robotics research and development.

Book your 30 minutes free consultation with our research experts

Global Cell Therapy Manufacturing Automation Market Segmentation

1) By Component: Hardware, Software, Services

2) By Cell Type: T-Cells, Stem Cells, Natural Killer (NK) Cells, Other Cell Types

3) By Process: Upstream Processing, Downstream Processing, Fill-Finish, Quality Control, Other Processes

4) By End-User: Pharmaceutical And Biotechnology Companies, Research Institutes, Contract Manufacturing Organizations (CMOs), Other End-Users

Subsegments:

1) By Hardware: Automated Bioreactor Systems, Robotic Handling Platforms, Automated Separation Devices, Automated Expansion Units, In Line Quality Analyzers

2) By Software: Electronic Batch Record Software, Manufacturing Execution Software, Workflow Management Software, Data Monitoring Software, Compliance Management Software

3) By Services: Installation Services, Maintenance Services, Validation Services, Training Services, Technical Support Services

What Is The Driver Of The Cell Therapy Manufacturing Automation Market?

The growing demand for gene therapies is expected to propel the growth of the cell therapy manufacturing automation market going forward. Gene therapy refers to a medical technique that involves modifying or replacing defective genes to treat or prevent diseases. The increasing demand for gene therapy is due to advancements in genetic sequencing and diagnostics, which enable precise identification of disease-causing genes for targeted treatment. Cell therapy manufacturing automation supports gene therapy by streamlining and standardizing complex production processes to ensure consistent quality and scalability. It enhances therapeutic development by reducing errors, improving efficiency, and enabling reliable large-scale manufacturing of gene-modified cells. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved six gene therapy products in 2023, up from five approvals in 2022. Therefore, the growing demand for gene therapies is driving the growth of the cell therapy manufacturing automation industry.

Key Players In The Global Cell Therapy Manufacturing Automation Market

Major companies operating in the cell therapy manufacturing automation market are Thermo Fisher Scientific Inc., Merck KGaA, Fujifilm Holdings Corporation, Corning Incorporated, Lonza Group AG, Cytiva, WuXi AppTecCo. Ltd., Hitachi High Technologies Corp., CatalentInc., Sartorius AG, Beckman Coulter Life Sciences, Terumo BCT Inc., Miltenyi Biotec, Oxford Biomedica Plc, National Resilience LLC, Minaris Regenerative Medicine LLC, Tulip Interfaces Inc., Invetech Pty Ltd., BlueRock Therapeutics LLC, Cellares Inc., Ascential Medical & Life Sciences, Cell and Gene Therapy Catapult

Global Cell Therapy Manufacturing Automation Market Trends and Insights

Major companies operating in the cell therapy manufacturing automation market are focusing on developing advanced solutions, such as automated cell therapy system, to connect multi-stage manufacturing workflows into unified, validated digital frameworks that reduce manual touchpoints and support regulatory compliance. An automated cell therapy system refers to an off-the-shelf validated automation solution that digitally connects cell therapy instruments (e.g., magnetic separation, centrifugation, electroporation, incubators) into a single interface, enabling traceability, repeatability, and cGMP compliance across production stages. For instance, in January 2024, Thermo Fisher Scientific Inc., a US-based life sciences company, launched Gibco CTS Cellmation Software, a first-of-its-kind automation solution. It is a first-of-its-kind, off-the-shelf validated software solution that digitally connects instruments from across Thermo Fisher’s cell therapy portfolio to automate manufacturing workflows. It includes a pre-validated automation system powered by Emerson’s DeltaV technology, enabling seamless integration and control of multiple instruments without costly custom projects, and it establishes traceable, repeatable workflows that help ensure compliance with cGMP and data security regulations, reducing manual touchpoints for ground therapy developers.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Cell Therapy Manufacturing Automation Market?

In July 2024, Cellular Origins Ltd., a UK-based provider of automated cell and gene therapy manufacturing solutions, acquired the Autologous Cell Therapy Industrial Automation (ACTIA) Platform IP for an undisclosed amount. With this acquisition, Cellular Origins expanded its automated manufacturing technology portfolio by advancing the Constellation robotic platform to improve scalability, reduce production bottlenecks, and support industrialized cell therapy manufacturing workflows. ACTIA Platform IP is a US-based intellectual property platform focused specifically on industrial automation solutions for autologous cell therapy manufacturing

Regional Insights

North America was the largest region in the cell therapy manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell Therapy Manufacturing Automation Market?

The cell therapy manufacturing automation market consists of revenues earned by entities by providing services such as automated cell processing, workflow integration, process monitoring and control, digital manufacturing execution, and equipment validation and maintenance. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell therapy manufacturing automation market also includes sales of automated cell culture systems, robotic liquid handling platforms, closed system bioreactors, process control software, and integrated manufacturing hardware. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell Therapy Manufacturing Automation Market Report 2026?

The cell therapy manufacturing automation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy manufacturing automation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Cell Therapy Manufacturing Automation Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$2.08 billion
Revenue Forecast In 2035	$3.58 billion
Growth Rate	CAGR of 14.8% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Component, Cell Type, Process, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Thermo Fisher Scientific Inc., Merck KGaA, Fujifilm Holdings Corporation, Corning Incorporated, Lonza Group AG, Cytiva, WuXi AppTecCo. Ltd., Hitachi High Technologies Corp., CatalentInc., Sartorius AG, Beckman Coulter Life Sciences, Terumo BCT Inc., Miltenyi Biotec, Oxford Biomedica Plc, National Resilience LLC, Minaris Regenerative Medicine LLC, Tulip Interfaces Inc., Invetech Pty Ltd., BlueRock Therapeutics LLC, Cellares Inc., Ascential Medical & Life Sciences, Cell and Gene Therapy Catapult
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Cell Therapy Manufacturing Automation Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Cell Therapy Manufacturing Automation Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Cell Therapy Manufacturing Automation Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Cell Therapy Manufacturing Automation Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Autonomous Systems, Robotics & Smart Mobility

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Biotechnology, Genomics & Precision Medicine

4.2. Major Trends

4.2.1 Automation In Cell Isolation And Expansion

4.2.2 Integrated Quality Control And Monitoring Systems

4.2.3 Closed-System Bioreactors For Sterile Manufacturing

4.2.4 Cryopreservation And Sample Management Automation

4.2.5 Digital Workflow And Gmp Compliance Solutions

5. Cell Therapy Manufacturing Automation Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies

5.2 Biotechnology Companies

5.3 Research Institutes

5.4 Contract Manufacturing Organizations (Cmos)

5.5 Academic Hospitals

6. Cell Therapy Manufacturing Automation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cell Therapy Manufacturing Automation Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Cell Therapy Manufacturing Automation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Cell Therapy Manufacturing Automation Market Size, Comparisons And Growth Rate Analysis

7.3. Global Cell Therapy Manufacturing Automation Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Cell Therapy Manufacturing Automation Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cell Therapy Manufacturing Automation Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cell Therapy Manufacturing Automation Market Segmentation

9.1. Global Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hardware, Software, Services

9.2. Global Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

T-Cells, Stem Cells, Natural Killer (NK) Cells, Other Cell Types

9.3. Global Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Upstream Processing, Downstream Processing, Fill-Finish, Quality Control, Other Processes

9.4. Global Cell Therapy Manufacturing Automation Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmaceutical And Biotechnology Companies, Research Institutes, Contract Manufacturing Organizations (CMOs), Other End-Users

9.5. Global Cell Therapy Manufacturing Automation Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Automated Bioreactor Systems, Robotic Handling Platforms, Automated Separation Devices, Automated Expansion Units, In Line Quality Analyzers

9.6. Global Cell Therapy Manufacturing Automation Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Electronic Batch Record Software, Manufacturing Execution Software, Workflow Management Software, Data Monitoring Software, Compliance Management Software

9.7. Global Cell Therapy Manufacturing Automation Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Installation Services, Maintenance Services, Validation Services, Training Services, Technical Support Services

10. Cell Therapy Manufacturing Automation Market Regional And Country Analysis

10.1. Global Cell Therapy Manufacturing Automation Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Cell Therapy Manufacturing Automation Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cell Therapy Manufacturing Automation Market

11.1. Asia-Pacific Cell Therapy Manufacturing Automation Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cell Therapy Manufacturing Automation Market

12.1. China Cell Therapy Manufacturing Automation Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cell Therapy Manufacturing Automation Market

13.1. India Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cell Therapy Manufacturing Automation Market

14.1. Japan Cell Therapy Manufacturing Automation Market Overview

14.2. Japan Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cell Therapy Manufacturing Automation Market

15.1. Australia Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cell Therapy Manufacturing Automation Market

16.1. Indonesia Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cell Therapy Manufacturing Automation Market

17.1. South Korea Cell Therapy Manufacturing Automation Market Overview

17.2. South Korea Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cell Therapy Manufacturing Automation Market

18.1. Taiwan Cell Therapy Manufacturing Automation Market Overview

18.2. Taiwan Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cell Therapy Manufacturing Automation Market

19.1. South East Asia Cell Therapy Manufacturing Automation Market Overview

19.2. South East Asia Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cell Therapy Manufacturing Automation Market

20.1. Western Europe Cell Therapy Manufacturing Automation Market Overview

20.2. Western Europe Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cell Therapy Manufacturing Automation Market

21.1. UK Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cell Therapy Manufacturing Automation Market

22.1. Germany Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cell Therapy Manufacturing Automation Market

23.1. France Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cell Therapy Manufacturing Automation Market

24.1. Italy Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cell Therapy Manufacturing Automation Market

25.1. Spain Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cell Therapy Manufacturing Automation Market

26.1. Eastern Europe Cell Therapy Manufacturing Automation Market Overview

26.2. Eastern Europe Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cell Therapy Manufacturing Automation Market

27.1. Russia Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cell Therapy Manufacturing Automation Market

28.1. North America Cell Therapy Manufacturing Automation Market Overview

28.2. North America Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cell Therapy Manufacturing Automation Market

29.1. USA Cell Therapy Manufacturing Automation Market Overview

29.2. USA Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cell Therapy Manufacturing Automation Market

30.1. Canada Cell Therapy Manufacturing Automation Market Overview

30.2. Canada Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cell Therapy Manufacturing Automation Market

31.1. South America Cell Therapy Manufacturing Automation Market Overview

31.2. South America Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cell Therapy Manufacturing Automation Market

32.1. Brazil Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cell Therapy Manufacturing Automation Market

33.1. Middle East Cell Therapy Manufacturing Automation Market Overview

33.2. Middle East Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cell Therapy Manufacturing Automation Market

34.1. Africa Cell Therapy Manufacturing Automation Market Overview

34.2. Africa Cell Therapy Manufacturing Automation Market, Segmentation By Component, Segmentation By Cell Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cell Therapy Manufacturing Automation Market Regulatory and Investment Landscape

36. Cell Therapy Manufacturing Automation Market Competitive Landscape And Company Profiles

36.1. Cell Therapy Manufacturing Automation Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Cell Therapy Manufacturing Automation Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Cell Therapy Manufacturing Automation Market Company Profiles

36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

37. Cell Therapy Manufacturing Automation Market Other Major And Innovative Companies

Cytiva, WuXi AppTecCo. Ltd., Hitachi High Technologies Corp., CatalentInc., Sartorius AG, Beckman Coulter Life Sciences, Terumo BCT Inc., Miltenyi Biotec, Oxford Biomedica Plc, National Resilience LLC, Minaris Regenerative Medicine LLC, Tulip Interfaces Inc., Invetech Pty Ltd., BlueRock Therapeutics LLC, Cellares Inc.

38. Global Cell Therapy Manufacturing Automation Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cell Therapy Manufacturing Automation Market

40. Cell Therapy Manufacturing Automation Market High Potential Countries, Segments and Strategies

40.1 Cell Therapy Manufacturing Automation Market In 2030 - Countries Offering Most New Opportunities

40.2 Cell Therapy Manufacturing Automation Market In 2030 - Segments Offering Most New Opportunities

40.3 Cell Therapy Manufacturing Automation Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Cell Therapy Manufacturing Automation Market, Overview Of Key Products - Product Examples

Table 2: Global Cell Therapy Manufacturing Automation Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Cell Therapy Manufacturing Automation Market, Supply Chain Analysis

Table 4: Global Cell Therapy Manufacturing Automation Market, Major Raw Material Providers

Table 5: Global Cell Therapy Manufacturing Automation Market, Major Resource Providers

Table 6: Global Cell Therapy Manufacturing Automation Market, Major Manufacturers (Suppliers)

Table 7: Global Cell Therapy Manufacturing Automation Market, Major Distributors And Channel Partners

Table 8: Global Cell Therapy Manufacturing Automation Market, Key Technologies & Future Trends

Table 9: Global Cell Therapy Manufacturing Automation Market, Major Trends

Table 10: Global Cell Therapy Manufacturing Automation Market, Major End Users

Table 11: Global Cell Therapy Manufacturing Automation Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Cell Therapy Manufacturing Automation Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Cell Therapy Manufacturing Automation Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Cell Therapy Manufacturing Automation Market - TAM, US$ Billion, 2025

Table 15: Global Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Cell Therapy Manufacturing Automation Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Cell Therapy Manufacturing Automation Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Cell Therapy Manufacturing Automation Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Cell Therapy Manufacturing Automation Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Cell Therapy Manufacturing Automation Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Cell Therapy Manufacturing Automation Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Cell Therapy Manufacturing Automation Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Cell Therapy Manufacturing Automation Market - Company Scoring Matrix

Table 98: Thermo Fisher Scientific Inc. Financial Performance

Table 99: Merck KGaA Financial Performance

Table 100: Fujifilm Holdings Corporation Financial Performance

Table 101: Corning Incorporated Financial Performance

Table 102: Lonza Group AG Financial Performance

Table 103: Global Cell Therapy Manufacturing Automation Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Cell Therapy Manufacturing Automation Market, Competitive Dashboard

Table 105: Global Cell Therapy Manufacturing Automation Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Cell Therapy Manufacturing Automation Market Size Gain ($ Billion), Segmentation By Component, 2025 – 2030

Table 107: Global, Cell Therapy Manufacturing Automation Market Size Gain ($ Billion), Segmentation By Cell Type, 2025 – 2030

Table 108: Global, Cell Therapy Manufacturing Automation Market Size Gain ($ Billion), Segmentation By Process, 2025 – 2030

List Of Figures

Figure 1: Global Cell Therapy Manufacturing Automation Market, Overview Of Key Products - Product Examples

Figure 2: Global Cell Therapy Manufacturing Automation Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Cell Therapy Manufacturing Automation Market, Supply Chain Analysis

Figure 4: Global Cell Therapy Manufacturing Automation Market, Major Raw Material Providers

Figure 5: Global Cell Therapy Manufacturing Automation Market, Major Resource Providers

Figure 6: Global Cell Therapy Manufacturing Automation Market, Major Manufacturers (Suppliers)

Figure 7: Global Cell Therapy Manufacturing Automation Market, Major Distributors And Channel Partners

Figure 8: Global Cell Therapy Manufacturing Automation Market, Key Technologies & Future Trends

Figure 9: Global Cell Therapy Manufacturing Automation Market, Major Trends

Figure 10: Global Cell Therapy Manufacturing Automation Market, Major End Users

Figure 11: Global Cell Therapy Manufacturing Automation Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Cell Therapy Manufacturing Automation Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Cell Therapy Manufacturing Automation Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Cell Therapy Manufacturing Automation Market - TAM, US$ Billion, 2025

Figure 15: Global Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Cell Therapy Manufacturing Automation Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Cell Therapy Manufacturing Automation Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Cell Therapy Manufacturing Automation Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Cell Therapy Manufacturing Automation Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Cell Therapy Manufacturing Automation Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Cell Therapy Manufacturing Automation Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Cell Therapy Manufacturing Automation Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Cell Therapy Manufacturing Automation Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Cell Therapy Manufacturing Automation Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Cell Therapy Manufacturing Automation Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Cell Therapy Manufacturing Automation Market - Company Scoring Matrix

Figure 98: Thermo Fisher Scientific Inc. Financial Performance

Figure 99: Merck KGaA Financial Performance

Figure 100: Fujifilm Holdings Corporation Financial Performance

Figure 101: Corning Incorporated Financial Performance

Figure 102: Lonza Group AG Financial Performance

Figure 103: Global Cell Therapy Manufacturing Automation Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Cell Therapy Manufacturing Automation Market, Competitive Dashboard

Figure 105: Global Cell Therapy Manufacturing Automation Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Cell Therapy Manufacturing Automation Market Size Gain ($ Billion), Segmentation By Component, 2025 – 2030

Figure 107: Global, Cell Therapy Manufacturing Automation Market Size Gain ($ Billion), Segmentation By Cell Type, 2025 – 2030

Figure 108: Global, Cell Therapy Manufacturing Automation Market Size Gain ($ Billion), Segmentation By Process, 2025 – 2030

In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

Latest Market Developments in Aseptic Connectors And Welders Industry: Forecast 2025–2029

Competitive and Market Trend Analysis of Atrial Fibrillation Devices Industry Through 2029

Industry Trends Show Bioabsorbable Surgical Mesh Market Set to Expand at 8.6% CAGR Until 2029

Strategic Report on Biodegradable Hemostat Market: Growth Opportunities and Emerging Challenges

Cell Therapy Technologies Market Report 2026 - Global Outlook – By Product (Consumables, Equipment, Systems And Software), By Cell Type (T-Cells, Stem Cells, Other Cell Types), By Process (Cell Processing, Cell Preservat...

Light Electric Vehicles Market Report 2026 - Global Outlook – By Vehicle Type (E-Bikes, E-Scooters, Light E-Motorcycles, Three-Wheeled Electric Vehicles), By Power Output (Up to 3 kW, 3 kW – 6 kW, Above 6 kW), By Battery...

Cell Therapy Market Report 2026 - Global Outlook – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy ), By Therapy Type (Allogeneic Therapies, ...

3D Cell Culture Technologies Market Report 2026 - Global Outlook – By Type (Scaffold-Based, Scaffold-Free, 3D Bioreactors ), By Application (Cancer Research, Stem Cell Research, Drug Discovery, Regenerative Medicine), By...

Prescription Lens Market Report 2026 - Global Outlook – By Type (Single Vision, Bifocal, Trifocal, Progressive, Active, Other Types), By Coating (Anti-Reflective, Scratch Resistant Coating, Anti-Fog Coating, Ultraviolet ...

Platelet Aggregation Devices Market Report 2026 - Global Outlook – By Product (Reagents, Systems, Consumables And Accessories), By Channel Configuration (Four Channel, Dual Channel, Eight Channel), By Technology (Optical...

Soil Amendments Market Report 2026 - Global Outlook – By Soil Type (Clay, Sand, Loam, Silt), By Crop Type (Cereals And Grains, Oilseeds And Pulses, Fruits And Vegetables, Other Crop Types), By Application (Construction A...

Frequently Asked Questions

How big is the Cell Therapy Manufacturing Automation Market?

The Cell Therapy Manufacturing Automation market was valued at $1.81 billion in 2025, increased to $2.08 billion in 2026, and is projected to reach $3.58 billion by 2030.

What is the Cell Therapy Manufacturing Automation market growth?

The global Cell Therapy Manufacturing Automation market is expected to grow at a CAGR of 14.5% from 2026 to 2035 to reach $3.58 billion by 2035.

Who are the key players in Cell Therapy Manufacturing Automation market?

Some Key Players in the Cell Therapy Manufacturing Automation market Include, Thermo Fisher Scientific Inc., Merck KGaA, Fujifilm Holdings Corporation, Corning Incorporated, Lonza Group AG, Cytiva, WuXi AppTecCo. Ltd., Hitachi High Technologies Corp., CatalentInc., Sartorius AG, Beckman Coulter Life Sciences, Terumo BCT Inc., Miltenyi Biotec, Oxford Biomedica Plc, National Resilience LLC, Minaris Regenerative Medicine LLC, Tulip Interfaces Inc., Invetech Pty Ltd., BlueRock Therapeutics LLC, Cellares Inc., Ascential Medical & Life Sciences, Cell and Gene Therapy Catapult .

What is the anticipated growth trend for the Cell Therapy Manufacturing Automation market?

Major trend in this market includes: Automation Software Integration Drives Workflow Standardization. For further insights on this market. request a sample here

Which region has the most growth potential in the Cell Therapy Manufacturing Automation market?

North America was the largest region in the cell therapy manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy manufacturing automation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.